首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal NDUFB2 Antibody

  • 中文名: NDUFB2抗体
  • 别    名: AGGG; CI-AGGG
货号: IPDX12547
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/25-1/100 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/2000-1/5000 Human,Mouse,Rat

产品详情

AliasesAGGG; CI-AGGG
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenSynthetic peptide of human NDUFB2
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是关于NDUFB2抗体的模拟参考文献示例,格式包含文献名称、作者及摘要概括:

---

1. **文献名称**: *NDUFB2在人类线粒体复合物I组装中的关键作用及其抗体应用*

**作者**: Smith J, Lee T, Patel R (2021)

**摘要**: 本研究通过Western blot和免疫沉淀技术,利用特异性NDUFB2抗体,揭示了NDUFB2亚基在线粒体复合物I组装中的必要性,并证明其缺失导致氧化磷酸化功能受损,为线粒体疾病机制提供新见解。

2. **文献名称**: *NDUFB2在结直肠癌中的表达调控及临床预后意义*

**作者**: Zhang L, Wang Y, Chen H (2019)

**摘要**: 通过免疫组化(使用NDUFB2抗体)和qPCR分析,发现NDUFB2在结直肠癌组织中显著低表达,且与患者生存率正相关,提示其可能作为潜在的肿瘤抑制标志物。

3. **文献名称**: *抗NDUFB2抗体在帕金森病模型中的线粒体功能障碍研究*

**作者**: Brown K, García M, Kim S (2018)

**摘要**: 采用NDUFB2抗体进行免疫荧光和蛋白质印迹,发现帕金森病模型中NDUFB2表达降低与复合物I活性下降相关,表明其参与多巴胺能神经元退行性变过程。

4. **文献名称**: *基于冷冻电镜的NDUFB2结构解析及抗体标记技术优化*

**作者**: Johnson R, Müller F (2020)

**摘要**: 结合NDUFB2抗体的特异性标记与冷冻电镜技术,首次解析了NDUFB2亚基在复合物I中的精确空间定位,为理解其电子传递功能提供结构基础。

---

**备注**:以上文献为模拟示例,实际文献需通过学术数据库(如PubMed、Web of Science)以关键词“NDUFB2 antibody”、“NDUFB2 complex I”等检索获取。建议结合具体研究方向筛选最新或高引论文。

背景信息

The NDUFB2 antibody is a specialized tool used to detect the NADH:ubiquinone oxidoreductase subunit B2 (NDUFB2), a core component of mitochondrial Complex I (NADH dehydrogenase) in the electron transport chain. Complex I, the largest respiratory complex, plays a critical role in oxidative phosphorylation by catalyzing electron transfer from NADH to ubiquinone, coupled with proton translocation. NDUFB2 is a nuclear-encoded, membrane-bound subunit integral to Complex I’s structural and functional integrity. Antibodies targeting NDUFB2 are essential for studying Complex I assembly, stability, and dysfunction linked to mitochondrial disorders (e.g., Leigh syndrome, Leber hereditary optic neuropathy) and metabolic diseases. These antibodies are validated for applications like Western blotting, immunofluorescence, and immunohistochemistry to assess protein expression, localization, and deficiency in tissues or cell models. Researchers also use NDUFB2 antibodies to explore metabolic alterations in cancer, neurodegeneration (e.g., Parkinson’s disease), and aging. High-quality NDUFB2 antibodies exhibit specificity confirmed by knockdown/knockout controls and cross-reactivity testing. Their utility extends to both basic mitochondrial biology and clinical research, aiding in diagnostics and therapeutic development for energy metabolism-related pathologies.

客户数据及评论

折叠内容

大包装询价

×